These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15769986)

  • 1. Oral contraceptives improve endothelial function in amenorrheic athletes.
    Rickenlund A; Eriksson MJ; Schenck-Gustafsson K; Hirschberg AL
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3162-7. PubMed ID: 15769986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile.
    Rickenlund A; Eriksson MJ; Schenck-Gustafsson K; Hirschberg AL
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1354-9. PubMed ID: 15572426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral contraceptives on body composition and physical performance in female athletes.
    Rickenlund A; Carlström K; Ekblom B; Brismar TB; Von Schoultz B; Hirschberg AL
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4364-70. PubMed ID: 15328063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Athletic amenorrhea and endothelial dysfunction.
    Hoch AZ; Jurva JW; Staton MA; Thielke R; Hoffmann RG; Pajewski N; Gutterman DD
    WMJ; 2007 Sep; 106(6):301-6. PubMed ID: 17970010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical atherosclerotic risk in endurance-trained premenopausal amenorrheic women.
    Augustine JA; Lefferts WK; Dowthwaite JN; Brann LS; Brutsaert TD; Heffernan KS
    Atherosclerosis; 2016 Jan; 244():157-64. PubMed ID: 26647371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
    Hartard M; Kleinmond C; Kirchbichler A; Jeschke D; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
    Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-mediated dilation in athletes: influence of aging.
    Montero D; Padilla J; Diaz-Cañestro C; Muris DM; Pyke KE; Obert P; Walther G
    Med Sci Sports Exerc; 2014 Nov; 46(11):2148-58. PubMed ID: 24963792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance.
    Rickenlund A; Thorén M; Nybacka A; Frystyk J; Hirschberg AL
    Hum Reprod; 2010 Jan; 25(1):85-93. PubMed ID: 19840988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an association between athletic amenorrhea and endothelial cell dysfunction?
    Zeni Hoch A; Dempsey RL; Carrera GF; Wilson CR; Chen EH; Barnabei VM; Sandford PR; Ryan TA; Gutterman DD
    Med Sci Sports Exerc; 2003 Mar; 35(3):377-83. PubMed ID: 12618566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral contraceptives on bone mass and stress fractures in female runners.
    Cobb KL; Bachrach LK; Sowers M; Nieves J; Greendale GA; Kent KK; Brown BW; Pettit K; Harper DM; Kelsey JL
    Med Sci Sports Exerc; 2007 Sep; 39(9):1464-73. PubMed ID: 17805075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of low dose oral contraceptives for the management of acne.
    Lemay A; Langley RG
    Skin Therapy Lett; 2002 Dec; 7(10):1-5. PubMed ID: 12658330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of passive smoking on endothelial function in: healthy adults.
    Holay MP; Paunikar NP; Joshi PP; Sahasrabhojney VS; Tankhiwale SR
    J Assoc Physicians India; 2004 Feb; 52():114-7. PubMed ID: 15656044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus.
    Sidhu JS; Cowan D; Kaski JC
    Am J Cardiol; 2004 Jul; 94(2):151-6. PubMed ID: 15246889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.